Truist Financial
NUTX

Truist Financial’s Nutex Health NUTX Stock Holding History

Truist Financial’s Portfolio NUTX Stock Details NUTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$4.58M Buy
26,814
+492
+2% +$62.3K 0.01% 961
2026
Q1 		$2.5M Buy
26,322
+1,903
+8% +$233K ﹤0.01% 1191
2025
Q4 		$4.02M Hold
24,419
– – 0.01% 946
2025
Q3 		$2.52M Hold
24,419
– – ﹤0.01% 1218
2025
Q2 		$3.04M Sell
24,419
-7,151
-23% -$924K ﹤0.01% 1091
2025
Q1 		$1.48M Sell
31,570
-4,000
-11% -$195K ﹤0.01% 1356
2024
Q4 		$1.13M Buy
35,570
+6,454
+22% +$184K ﹤0.01% 1497
2024
Q3 		$632K Hold
29,116
– – ﹤0.01% 1744
2024
Q2 		$173K Buy
29,116
+1
+0% +$7 ﹤0.01% 2541
2024
Q1 		$419K Hold
29,115
– – ﹤0.01% 2076
2023
Q4 		$786K Buy
29,115
+13,459
+86% +$420K ﹤0.01% 1729
2023
Q3 		$476K Sell
15,656
-7,333
-32% -$354K ﹤0.01% 1949
2023
Q2 		$1.45M Buy
22,989
+20,591
+859% +$1.77M ﹤0.01% 1404
2023
Q1 		$363K Hold
2,398
– – ﹤0.01% 2160
2022
Q4 		$683K Buy
+2,398
New +$461K ﹤0.01% 1754

Other funds holding NUTX

PP
Pertento Partners London, United Kingdom $1.86B AUM 53.86% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
WC
Winmill & Co Walpole, New Hampshire $452M AUM 56.84% 1-Year Est. Return
Focus Partners Wealth
Focus Partners Wealth Boston, Massachusetts $97.6B AUM 29.43% 1-Year Est. Return

Truist Financial's NUTX Position: Q2 2026 in Review

Truist Financial increased its Nutex Health (NUTX) stake by 1.9% in Q2 2026, buying an estimated $62.3K and bringing the position to 26,814 shares worth $4.58M. The position accounts for 0.01% of the portfolio, ranked #961.

Truist Financial first reported a position in NUTX in Q4 2022 and has held it in 15 quarters since. 154 funds tracked by Wall St. Rank hold NUTX as of Q2 2026.

  • Truist Financial held 26,814 shares of Nutex Health worth $4.58M as of Q2 2026.
  • Truist Financial bought 492 Nutex Health shares in Q2 2026, an estimated $62.3K.
  • Nutex Health made up 0.01% of Truist Financial's portfolio in Q2 2026, its #961 holding.
  • Truist Financial first reported a position in Nutex Health in Q4 2022 and has held it in 15 quarters since.
  • 154 funds tracked by Wall St. Rank held Nutex Health as of Q2 2026.

Based on Truist Financial's 13F filing for Q2 2026, filed 28 Jul 2026.